Laurie Toich, Assistant Editor

RAS proteins inhibited by the newly created NS1 monobody.

The 14th Report on Carcinogens added 5 viruses and 2 substances to the list of known carcinogens.

What does the defeat of California’s lower drug cost initiative mean for residents?

Testimony from women at different stages of life highlights the uncertainty of women’s healthcare without the Affordable Care Act.

The FDA is asking for additional information about HEPLISAV-B.

New findings draw parallels between Alzheimer’s disease and diabetes.

Women with genetic variants had lower hepatitis C viral levels after childbirth.

AXIM Biotech plans to conduct clinical trials of cannabis-based MedChew Rx in patients with multiple sclerosis.

Top news of the day from across the healthcare landscape.

New research is continuously identifying the underlying mechanisms of inflammatory arthritis, which leads to better understanding of the disease and new treatments.

A better understanding of the mechanisms of arthritis is needed to develop superior treatments.

Individuals with hepatitis C virus genotypes 1 -3 benefitted from treatment with MK-3682B

Flu vaccine market estimated to grow by $1 billion over the next decade.

Scientists discovered an excipient that improved absorption of a prostate cancer drug 3-fold.

New drugs for psoriatic arthritis discussed during a session at the ACR/ARHP conference.

Top news of the day from across the healthcare landscape.

Testimony from women at different stages of life highlights the uncertainty of women’s healthcare without the Affordable Care Act.

An ACR session focused on the Sunshine Act and health care transparency.

Ibrance has received approval from the European Commission to treat metastatic breast cancer.

Investigators have discovered that 2 PARP proteins are involved with arterial diseases.

Facebook and Twitter posts targeted at medical residences could potentially reduce antibiotic resistance.

Top news of the day from across the healthcare landscape.

New guidelines for rheumatoid arthritis treatment discussed at ACR conference.

PKC (midostaurin) granted priority review in cancer and an immune condition.

Lexicon Pharmaceuticals and Bristol-Myers Squibb launch drug discovery alliance.

ACR session reinforces the need for new research about how the genome, epigenome, and other factors play a role in rheumatoid arthritis.

Comparing healthy and cancerous cells from the same individual could allow for a better understanding of translocations involved.

Foundation Medicine and Sarah Cannon Research Institute work together to increase access to clinical trials for personalized oncology treatments.

Top news of the day from across the healthcare landscape.

Opdivo is the first PD-1 checkpoint inhibitor approved by the FDA.